Country: United States
Language: English
Source: NLM (National Library of Medicine)
DIBUCAINE (UNII: L6JW2TJG99) (DIBUCAINE - UNII:L6JW2TJG99)
GERITREX LLC
TOPICAL
OTC DRUG
For temporary relief of pain and itching associated with sunburn, minor burns, hemorrhoids, cuts, scratches, insect bites, stings
OTC monograph final
DIBUCAINE- DIBUCAINE OINTMENT GERITREX LLC _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- DIBUCAINE OINTMENT DRUG FACTS Active ingredient Purpose Dibucaine 1% Topical Anesthetic US ES For temporary relief of pain and itching associated with sunburn, minor burns, hemorrhoids, cuts, scratches, insect bites, stings DIRECTIONS Not for prolonged use Adults should not use more than 1oz in 24 hours or 1/4 oz for child Apply to affected area 3 or 4 times daily Cover with light dressing, if necessary WARNINIGS For External Use Only Do not get into the eyes. Stop use and ask a doctor if the condition persists of if rash and irritation develops. you have rectal bleeding INACTIVE INGREDIENTS Aceton Sodium Bisulfate, Lanolin, Mineral Oil, Purified water, White Petrolatum KEEP OUT OF REACH OF CHILDREN In the event of accidental ingestion, contact a Poison Control Center right away Store at room temperature 15-30'C (59-86'F) Apply to affected area 3 or 4 times daily DIBUCAINE dibucaine ointment PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:5416 2-0 11 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH DIBUCAINE (UNII: L6 JW2TJG9 9 ) (DIBUCAINE - UNII:L6 JW2TJG9 9 ) DIBUCAINE 0 .28 g in 28 g INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH ACETO NE SO DIUM BISULFITE (UNII: 47VY0 54OXY) LANO LIN (UNII: 7EV6 5EAW6 H) MINERAL O IL (UNII: T5L8 T28 FGP) GERITREX LLC WATER (UNII: 0 59 QF0 KO0 R) PETRO LATUM (UNII: 4T6 H12BN9 U) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:5416 2-0 11-0 1 28 g in 1 TUBE; Type 0 : No t a Co mbinatio n Pro duct 0 7/31/20 15 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE OTC mo no graph final pa rt346 0 7/31/20 15 LABELER - GERIT R Read the complete document